 Krishna Mallela
Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dystrophin | 7 | 2024 | 41 | 3.210 |
Why?
| | Silicone Oils | 3 | 2026 | 37 | 2.680 |
Why?
| | Utrophin | 6 | 2017 | 7 | 2.620 |
Why?
| | Microfilament Proteins | 6 | 2017 | 135 | 2.440 |
Why?
| | Protein Aggregates | 7 | 2025 | 84 | 2.260 |
Why?
| | Calcium-Binding Proteins | 6 | 2017 | 221 | 2.110 |
Why?
| | Antibodies, Monoclonal | 5 | 2025 | 1505 | 2.040 |
Why?
| | Protein Binding | 18 | 2025 | 2235 | 1.990 |
Why?
| | Protein Unfolding | 6 | 2018 | 33 | 1.760 |
Why?
| | Interferon-alpha | 4 | 2018 | 193 | 1.670 |
Why?
| | Actins | 6 | 2017 | 424 | 1.660 |
Why?
| | Spike Glycoprotein, Coronavirus | 3 | 2022 | 129 | 1.470 |
Why?
| | Drug Compounding | 3 | 2025 | 107 | 1.440 |
Why?
| | Polysorbates | 2 | 2025 | 42 | 1.400 |
Why?
| | Protein Folding | 15 | 2010 | 276 | 1.350 |
Why?
| | Thermodynamics | 12 | 2024 | 419 | 1.330 |
Why?
| | Antibodies, Neutralizing | 3 | 2022 | 340 | 1.300 |
Why?
| | Protein Stability | 9 | 2025 | 176 | 1.120 |
Why?
| | Cytochromes c | 6 | 2011 | 53 | 1.100 |
Why?
| | Preservatives, Pharmaceutical | 3 | 2014 | 28 | 1.100 |
Why?
| | Calorimetry | 2 | 2025 | 69 | 1.030 |
Why?
| | Dependovirus | 2 | 2025 | 78 | 1.010 |
Why?
| | Genetic Vectors | 2 | 2025 | 335 | 0.950 |
Why?
| | Proteins | 6 | 2026 | 1022 | 0.900 |
Why?
| | Poloxamer | 1 | 2025 | 10 | 0.890 |
Why?
| | Dystrophin-Associated Proteins | 1 | 2024 | 6 | 0.870 |
Why?
| | Benzyl Alcohol | 3 | 2014 | 12 | 0.860 |
Why?
| | Immunoglobulin G | 3 | 2025 | 887 | 0.850 |
Why?
| | Protein Conformation | 8 | 2018 | 936 | 0.840 |
Why?
| | Models, Molecular | 15 | 2018 | 1597 | 0.830 |
Why?
| | Surface Plasmon Resonance | 1 | 2024 | 87 | 0.800 |
Why?
| | Protein Structure, Secondary | 14 | 2019 | 371 | 0.790 |
Why?
| | Antibodies | 1 | 2025 | 397 | 0.780 |
Why?
| | Protein Isoforms | 1 | 2024 | 396 | 0.770 |
Why?
| | Flavin-Adenine Dinucleotide | 1 | 2022 | 15 | 0.760 |
Why?
| | Protein Structure, Tertiary | 10 | 2021 | 855 | 0.750 |
Why?
| | Biological Products | 1 | 2026 | 257 | 0.740 |
Why?
| | Mutation, Missense | 3 | 2014 | 335 | 0.730 |
Why?
| | Drug Stability | 4 | 2026 | 169 | 0.720 |
Why?
| | Methionine | 2 | 2019 | 161 | 0.700 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2025 | 992 | 0.690 |
Why?
| | Anti-Infective Agents | 2 | 2014 | 232 | 0.650 |
Why?
| | Chemistry, Pharmaceutical | 3 | 2026 | 112 | 0.650 |
Why?
| | Amyloid beta-Peptides | 1 | 2022 | 244 | 0.620 |
Why?
| | Asparagine | 1 | 2019 | 35 | 0.600 |
Why?
| | Protein Subunits | 2 | 2012 | 229 | 0.560 |
Why?
| | Excipients | 1 | 2018 | 55 | 0.550 |
Why?
| | Oxidants | 1 | 2018 | 99 | 0.540 |
Why?
| | Horses | 9 | 2012 | 224 | 0.520 |
Why?
| | Protein Domains | 3 | 2024 | 311 | 0.520 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2017 | 56 | 0.520 |
Why?
| | Lymphokines | 1 | 2017 | 128 | 0.510 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2017 | 41 | 0.510 |
Why?
| | Ketones | 1 | 2017 | 50 | 0.500 |
Why?
| | Aldehydes | 1 | 2017 | 139 | 0.490 |
Why?
| | Recombinant Proteins | 5 | 2021 | 1368 | 0.470 |
Why?
| | Protein Denaturation | 5 | 2011 | 76 | 0.460 |
Why?
| | Molecular Chaperones | 1 | 2017 | 199 | 0.460 |
Why?
| | Oxidation-Reduction | 6 | 2019 | 1066 | 0.460 |
Why?
| | Circular Dichroism | 4 | 2025 | 151 | 0.450 |
Why?
| | Light | 1 | 2018 | 403 | 0.450 |
Why?
| | Cresols | 2 | 2014 | 4 | 0.440 |
Why?
| | Kinetics | 11 | 2024 | 1567 | 0.440 |
Why?
| | Adsorption | 2 | 2025 | 152 | 0.430 |
Why?
| | Amino Acid Sequence | 6 | 2018 | 2127 | 0.420 |
Why?
| | Binding Sites | 4 | 2023 | 1309 | 0.410 |
Why?
| | Amino Acid Substitution | 1 | 2014 | 302 | 0.400 |
Why?
| | Antiviral Agents | 1 | 2018 | 767 | 0.370 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2025 | 192 | 0.330 |
Why?
| | Hydrogen-Ion Concentration | 8 | 2025 | 531 | 0.330 |
Why?
| | Biophysical Phenomena | 4 | 2015 | 67 | 0.320 |
Why?
| | Cytochrome c Group | 5 | 2004 | 43 | 0.320 |
Why?
| | Muscular Dystrophies | 1 | 2010 | 28 | 0.320 |
Why?
| | Molecular Sequence Data | 5 | 2015 | 2881 | 0.300 |
Why?
| | Mutation | 5 | 2022 | 4071 | 0.300 |
Why?
| | Humans | 20 | 2026 | 145140 | 0.270 |
Why?
| | Surface-Active Agents | 2 | 2020 | 98 | 0.270 |
Why?
| | Hydrogen | 6 | 2004 | 73 | 0.260 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 4 | 2018 | 345 | 0.240 |
Why?
| | Particle Size | 2 | 2025 | 381 | 0.240 |
Why?
| | Cell Line, Tumor | 3 | 2018 | 3539 | 0.240 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2017 | 145 | 0.230 |
Why?
| | Silicon | 1 | 2025 | 19 | 0.230 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2024 | 2136 | 0.220 |
Why?
| | Syringes | 1 | 2025 | 49 | 0.220 |
Why?
| | Single-Domain Antibodies | 1 | 2025 | 16 | 0.220 |
Why?
| | Serogroup | 1 | 2025 | 45 | 0.220 |
Why?
| | Emulsions | 1 | 2025 | 59 | 0.220 |
Why?
| | Osmolar Concentration | 1 | 2025 | 168 | 0.220 |
Why?
| | Filtration | 1 | 2025 | 68 | 0.220 |
Why?
| | beta-Arrestins | 1 | 2024 | 15 | 0.210 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2015 | 387 | 0.210 |
Why?
| | Molecular Docking Simulation | 1 | 2024 | 119 | 0.210 |
Why?
| | Entropy | 1 | 2024 | 44 | 0.200 |
Why?
| | Receptors, Opioid, mu | 1 | 2024 | 66 | 0.200 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2024 | 93 | 0.200 |
Why?
| | Animals | 13 | 2026 | 37952 | 0.200 |
Why?
| | Protein Interaction Mapping | 1 | 2024 | 105 | 0.200 |
Why?
| | Receptors, Virus | 1 | 2023 | 95 | 0.190 |
Why?
| | Amino Acids | 2 | 2019 | 519 | 0.190 |
Why?
| | Morphine | 1 | 2024 | 168 | 0.190 |
Why?
| | NADH, NADPH Oxidoreductases | 1 | 2022 | 23 | 0.190 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2022 | 36 | 0.190 |
Why?
| | HEK293 Cells | 2 | 2024 | 740 | 0.190 |
Why?
| | Benzoquinones | 1 | 2022 | 46 | 0.180 |
Why?
| | Mutant Proteins | 2 | 2014 | 105 | 0.180 |
Why?
| | NAD | 1 | 2022 | 79 | 0.180 |
Why?
| | Fluorescent Dyes | 4 | 2012 | 333 | 0.180 |
Why?
| | Deuterium Exchange Measurement | 3 | 2007 | 26 | 0.180 |
Why?
| | Antigen-Antibody Reactions | 1 | 2021 | 49 | 0.170 |
Why?
| | Transition Temperature | 1 | 2021 | 28 | 0.170 |
Why?
| | Immune Evasion | 1 | 2022 | 61 | 0.170 |
Why?
| | Saccharomyces cerevisiae | 1 | 2025 | 572 | 0.160 |
Why?
| | Cell Proliferation | 2 | 2018 | 2504 | 0.160 |
Why?
| | Protein Multimerization | 2 | 2012 | 204 | 0.160 |
Why?
| | Polyethylene Glycols | 1 | 2025 | 649 | 0.160 |
Why?
| | Escherichia coli | 2 | 2014 | 834 | 0.150 |
Why?
| | tert-Butylhydroperoxide | 1 | 2018 | 9 | 0.140 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2019 | 376 | 0.140 |
Why?
| | Amidines | 1 | 2018 | 13 | 0.140 |
Why?
| | Cytotoxicity Tests, Immunologic | 1 | 2018 | 38 | 0.140 |
Why?
| | Protein Aggregation, Pathological | 1 | 2018 | 18 | 0.140 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 2017 | 627 | 0.140 |
Why?
| | Temperature | 2 | 2012 | 632 | 0.140 |
Why?
| | Nanoparticles | 2 | 2025 | 516 | 0.130 |
Why?
| | Models, Biological | 4 | 2008 | 1763 | 0.130 |
Why?
| | Proteolysis | 1 | 2018 | 172 | 0.130 |
Why?
| | Receptors, Fc | 1 | 2018 | 54 | 0.130 |
Why?
| | Unfolded Protein Response | 1 | 2017 | 58 | 0.130 |
Why?
| | Molecular Weight | 1 | 2017 | 312 | 0.130 |
Why?
| | Hydrolysis | 1 | 2017 | 197 | 0.130 |
Why?
| | Solubility | 1 | 2017 | 240 | 0.130 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2018 | 202 | 0.120 |
Why?
| | Hydrogen Peroxide | 1 | 2018 | 335 | 0.120 |
Why?
| | Adenosine Triphosphatases | 1 | 2017 | 159 | 0.120 |
Why?
| | Structural Homology, Protein | 1 | 2015 | 22 | 0.120 |
Why?
| | Carbocyanines | 3 | 2001 | 37 | 0.110 |
Why?
| | Mass Spectrometry | 1 | 2018 | 728 | 0.110 |
Why?
| | Ethylene Glycols | 1 | 2014 | 17 | 0.110 |
Why?
| | Phenol | 1 | 2014 | 15 | 0.110 |
Why?
| | Liposomes | 2 | 2025 | 259 | 0.100 |
Why?
| | SUMO-1 Protein | 1 | 2014 | 18 | 0.100 |
Why?
| | Bacterial Load | 1 | 2014 | 67 | 0.100 |
Why?
| | Chromatography, Gel | 1 | 2014 | 130 | 0.100 |
Why?
| | Cysteine Endopeptidases | 1 | 2014 | 74 | 0.100 |
Why?
| | Biochemistry | 2 | 2008 | 36 | 0.100 |
Why?
| | Area Under Curve | 1 | 2014 | 329 | 0.100 |
Why?
| | Cloning, Molecular | 1 | 2014 | 537 | 0.100 |
Why?
| | Pyrenes | 1 | 2012 | 6 | 0.100 |
Why?
| | Crystallography, X-Ray | 1 | 2014 | 485 | 0.090 |
Why?
| | Solutions | 1 | 2012 | 159 | 0.090 |
Why?
| | In Vitro Techniques | 2 | 2010 | 1048 | 0.090 |
Why?
| | Cattle | 1 | 2014 | 946 | 0.090 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2014 | 356 | 0.090 |
Why?
| | Caveolae | 1 | 2001 | 16 | 0.080 |
Why?
| | Cysteine | 1 | 2012 | 210 | 0.080 |
Why?
| | Sequence Alignment | 1 | 2012 | 362 | 0.080 |
Why?
| | Recombinant Fusion Proteins | 1 | 2014 | 666 | 0.080 |
Why?
| | Membrane Lipids | 1 | 2001 | 82 | 0.080 |
Why?
| | Solvents | 1 | 2010 | 112 | 0.080 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2010 | 155 | 0.080 |
Why?
| | Spectrometry, Fluorescence | 2 | 2005 | 165 | 0.080 |
Why?
| | Anesthetics, Local | 1 | 2010 | 104 | 0.080 |
Why?
| | Multiprotein Complexes | 1 | 2010 | 172 | 0.070 |
Why?
| | Lipid Bilayers | 1 | 1999 | 103 | 0.070 |
Why?
| | Cell Line | 1 | 2014 | 2821 | 0.070 |
Why?
| | Micrococcal Nuclease | 1 | 2008 | 26 | 0.070 |
Why?
| | Phosphatidylcholines | 1 | 1997 | 130 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 3892 | 0.060 |
Why?
| | Models, Chemical | 4 | 2008 | 250 | 0.060 |
Why?
| | Receptors, GABA | 1 | 2005 | 13 | 0.060 |
Why?
| | Methyl Ethers | 1 | 2005 | 19 | 0.060 |
Why?
| | Halothane | 1 | 2005 | 8 | 0.060 |
Why?
| | Ferric Compounds | 1 | 2025 | 54 | 0.050 |
Why?
| | Anesthetics, Inhalation | 1 | 2005 | 52 | 0.050 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2005 | 228 | 0.050 |
Why?
| | Flow Cytometry | 1 | 2025 | 1159 | 0.040 |
Why?
| | Fluorescence Polarization | 2 | 2001 | 24 | 0.040 |
Why?
| | Gene Transfer Techniques | 1 | 2021 | 186 | 0.040 |
Why?
| | Genetic Therapy | 1 | 2021 | 315 | 0.040 |
Why?
| | Egg Proteins | 1 | 2007 | 20 | 0.030 |
Why?
| | Muramidase | 1 | 2007 | 67 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2024 | 1145 | 0.030 |
Why?
| | Amino Acid Motifs | 1 | 2005 | 219 | 0.030 |
Why?
| | Probability | 1 | 2005 | 307 | 0.030 |
Why?
| | Time Factors | 2 | 2004 | 7107 | 0.020 |
Why?
| | Biophysics | 1 | 2002 | 75 | 0.020 |
Why?
| | Tritium | 1 | 2001 | 67 | 0.020 |
Why?
| | Hydrogen Bonding | 1 | 2001 | 169 | 0.020 |
Why?
| | Rotation | 1 | 2001 | 121 | 0.020 |
Why?
| | Monte Carlo Method | 1 | 2001 | 147 | 0.020 |
Why?
| | History, 20th Century | 1 | 2001 | 327 | 0.020 |
Why?
| | Surface Properties | 1 | 2001 | 386 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2001 | 591 | 0.020 |
Why?
| | Fatty Acids, Unsaturated | 1 | 1999 | 96 | 0.020 |
Why?
| | Sucrose | 1 | 1999 | 114 | 0.020 |
Why?
| | Guanidine | 1 | 2008 | 21 | 0.020 |
Why?
| | Molecular Structure | 1 | 1999 | 486 | 0.020 |
Why?
| | Enzyme Stability | 1 | 2007 | 73 | 0.020 |
Why?
| | Amides | 1 | 2007 | 101 | 0.020 |
Why?
| | Protons | 1 | 2006 | 96 | 0.010 |
Why?
| | Models, Theoretical | 1 | 2008 | 556 | 0.010 |
Why?
| | Titrimetry | 1 | 2003 | 12 | 0.010 |
Why?
| | Spectrum Analysis | 1 | 2003 | 85 | 0.010 |
Why?
| | Proteomics | 1 | 2008 | 1185 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2008 | 3410 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2005 | 2588 | 0.010 |
Why?
|
|
Mallela's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|